Fieldview Capital Management LLC Reduces Holdings in Danaher Corporation $DHR

Fieldview Capital Management LLC reduced its stake in Danaher Corporation (NYSE:DHR) by 68.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,456 shares of the conglomerate’s stock after selling 3,151 shares during the period. Fieldview Capital Management LLC’s holdings in Danaher were worth $289,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Sivia Capital Partners LLC boosted its position in Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after buying an additional 119 shares during the period. Prospera Financial Services Inc increased its position in shares of Danaher by 16.0% in the second quarter. Prospera Financial Services Inc now owns 4,972 shares of the conglomerate’s stock valued at $983,000 after acquiring an additional 684 shares during the period. Los Angeles Capital Management LLC raised its stake in shares of Danaher by 2.2% during the second quarter. Los Angeles Capital Management LLC now owns 3,297 shares of the conglomerate’s stock valued at $651,000 after acquiring an additional 71 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Danaher by 3.2% during the second quarter. Acadian Asset Management LLC now owns 51,051 shares of the conglomerate’s stock worth $10,083,000 after purchasing an additional 1,596 shares during the period. Finally, ProShare Advisors LLC grew its stake in shares of Danaher by 11.2% in the second quarter. ProShare Advisors LLC now owns 116,909 shares of the conglomerate’s stock worth $23,094,000 after purchasing an additional 11,771 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR opened at $195.16 on Thursday. The company has a 50-day simple moving average of $220.51 and a two-hundred day simple moving average of $215.69. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. The firm has a market capitalization of $138.00 billion, a PE ratio of 38.72, a price-to-earnings-growth ratio of 2.64 and a beta of 0.93. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same quarter in the prior year, the business earned $2.14 EPS. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a yield of 0.8%. Danaher’s payout ratio is currently 25.40%.

Analyst Ratings Changes

A number of research analysts recently issued reports on DHR shares. HSBC boosted their price target on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Monday, December 1st. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. KeyCorp reissued an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. Evercore restated an “outperform” rating and set a $254.00 target price on shares of Danaher in a report on Wednesday, January 28th. Finally, JPMorgan Chase & Co. raised their price target on Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $253.86.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.